Search

Scientists create virus cocktail that kills deadly superbugs

Monash University breakthrough uses safe, lab-grown viruses to wipe out drug-resistant infections and could transform hospital treatments.

MN Report 12:41 PM, 25 Sep, 2025
Scientists create virus cocktail that kills deadly superbugs
Caption: The study, published inNature Microbiology, was led by Professor Jeremy J. Barr from the Monash University School of Biological Sciences, with Professor Anton Peleg from the Department of Infectious Diseases, The Alfred and Monash University as co-senior author, and represents a new approach for precision medicine in hospitals battling antimicrobial resistance (AMR).

New virus cocktail shows powerful results against drug-resistant infections

In a medical breakthrough that could save countless lives, scientists at Monash University and The Alfred have developed a virus cocktail that targets some of the deadliest drug-resistant infections seen in hospitals. The treatment, called Entelli-02, uses naturally occurring bacterial viruses — known as bacteriophages — to destroy superbugs that no longer respond to antibiotics.

Drug-resistant infections are a growing global health crisis, linked to more than 200,000 deaths in 2019. Now, researchers have created Entelli-02, a unique mix of five bacteriophages designed to seek out and kill Enterobacter infections — a group of dangerous bacteria that often resist even last-line antibiotics.

“This is the first time we’ve built a hospital-ready phage therapy product to fight a drug-resistant bacterial pathogen,” said Professor Jeremy J. Barr, senior author of the study published in Nature Microbiology.

Why this matters

Superbugs are a serious challenge for hospitals worldwide. They spread quickly, are difficult to treat, and can turn routine procedures into life-threatening situations. By using bacteriophages — viruses that attack only bacteria — scientists can precisely eliminate the infection without harming healthy cells.

How it works

  • Five viruses, one goal: Entelli-02 combines five carefully selected phages to attack the bacteria from multiple angles.
  • Proven results: In preclinical tests, the therapy cut bacterial loads by over 99% in infected mice.
  • Safe for use: Manufactured to therapeutic-grade standards, it meets strict sterility and safety criteria for hospital use.

What’s next

Entelli-02 is already available for compassionate use under Australia’s Therapeutic Goods Administration program, and clinical trials are being planned to confirm its effectiveness in patients.

“This is a blueprint for hospitals worldwide to respond to superbug outbreaks with precision treatments,” Professor Barr said.


Stay informed and protect your health!

CLICK HERE TO JOIN Medical News Pakistan on WhatsApp for expert tips, health updates, and the latest medical research straight to your phone.